|
The photo shows from left to right:
Richard Bonner, UK; Dr Robert Johnson,
Chairman Rapid Microbiological Methods (RMM) Working Group, Dialogue,
Switzerland; Colin Booth, Oxoid, UK; Daniel Scheidegger, Chairman of the ECA Advisory Board, Genzyme
Pharmaceuticals, Switzerland; Dr Bernd Renger, Chairman of the European QP
Association, Vetter Pharma-Fertigung, Germany; Dr Ludwig Huber, Agilent
Technologies, Germany; Dr Boris Pimentel, DSM Nutritional Products,
Switzerland; Matt Moran, PharmaChemical Ireland, Ireland; Dr Wolfgang
Schumacher, F. Hoffmann-La Roche, Switzerland.
|